<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is known to cause ascending thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> (ATAAs) </plain></SENT>
<SENT sid="1" pm="."><plain>Transforming growth factor beta (TGF-beta) has recently been implicated in this process </plain></SENT>
<SENT sid="2" pm="."><plain>Imbalances between the matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs) have also been shown to contribute to <z:hpo ids='HP_0002617'>aneurysm</z:hpo> formation </plain></SENT>
<SENT sid="3" pm="."><plain>Whether and to what degree MMP, TIMP, and TGF-beta signaling profiles are altered in ATAAs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> compared with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients remains unknown </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: ATAA samples taken during aortic replacement from age-matched <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (n=9) and non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (n=18) patients were assessed for representative subtypes of <z:hpo ids='HP_0000001'>all</z:hpo> MMP classes, <z:hpo ids='HP_0000001'>all</z:hpo> 4 known TIMPs, and type 2 TGF-beta receptors (TGFBR2) </plain></SENT>
<SENT sid="5" pm="."><plain>Results were expressed as a percentage (mean+/-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) of reference control samples (100%; n=18) obtained from patients without ATAA </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, decreased MMP-2 (76+/-7; P&lt;0.05 versus control), increased MMP-12 (161+/-27% versus control; P&lt;0.05), and increased MT1-MMP (248+/-64% versus 91+/-21 non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and control; P&lt;0.05) were observed </plain></SENT>
<SENT sid="7" pm="."><plain>TIMP-3 (74+/-23%) was reduced compared with control values (P&lt;0.05) and TIMP-2 was elevated (128+/-31%) compared with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (73+/-19%; P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>In non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> samples, MMP-1 (70+/-16%), MMP-3 (77+/-18%), MMP-8 (75+/-11%), MMP-9 (69+/-14%), and MMP-12 (85+/-15%) were decreased compared with control (P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>TIMPs 1 to 3 were reduced in non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> compared with control values (P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>TGFBR2 were increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (193+/-32%) compared with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> (95+/-16%) and controls (P&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: A unique MMP and TIMP portfolio was observed in ATAAs from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> compared with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients </plain></SENT>
<SENT sid="12" pm="."><plain>In addition, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> samples showed evidence of increased TGF-beta signaling </plain></SENT>
<SENT sid="13" pm="."><plain>These differences suggest disparate mechanisms of extracellular matrix remodeling between these 2 groups of patients </plain></SENT>
</text></document>